News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Option Period Extended on Becton Dickinson AG - Tyrian Diagnostics Agreement



5/13/2009 9:55:45 AM

SYDNEY--(BUSINESS WIRE)--Tyrian Diagnostics Limited (ASX:TDX) announced today that Tyrian and BD (Becton, Dickinson and Company) have entered an extended option period under their current agreement. The extension will allow further feasibility studies of the suitability of Tyrian’s proprietary tuberculosis (TB) protein markers for the development of rapid diagnostic tests to detect active TB disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES